Related Experiment Video

Updated: Jul 4, 2026

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

Caspase-mediated cleavage of the signal-transducing IL-6 receptor subunit gp130

Dirk Graf1, Katrin Haselow, Ivo Münks

  • 1Department of Gastroenterology, Hepatology and Infectiology, Heinrich-Heine University, Moorenstrasse 5, D-40225 Düsseldorf, Germany. DirkGraf@gmx.net

Archives of Biochemistry and Biophysics
|July 3, 2008
PubMed

Insights

This study reveals how CD95 Ligand (CD95L) inhibits Interleukin-6 (IL-6) signaling. CD95L activates caspases, leading to gp130 cleavage and blocking IL-6

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Immunology

Background:

  • Interleukin-6 (IL-6) signaling is crucial for hepatoprotective effects against toxins.
  • CD95 Ligand (CD95L) is known to inhibit IL-6 signaling pathways.
  • Understanding this inhibition mechanism is key to liver protection research.

Purpose of the Study:

  • To elucidate the molecular mechanisms behind CD95L-induced inhibition of IL-6 signaling.
  • To identify the role of caspases and gp130 in this inhibitory pathway.
  • To investigate how this interaction impacts IL-6's hepatoprotective functions.

Main Methods:

  • Investigated CD95L-induced caspase activation and its effect on gp130.
  • Utilized caspase inhibitors (caspase 3 and 8) to block gp130 degradation.
  • Employed site-directed mutagenesis to alter a specific caspase cleavage site in gp130.
  • Analyzed STAT3 and SHP2 phosphorylation levels.
  • Detected gp130 cleavage products using in vitro assays.

Main Results:

  • CD95L triggers caspase activation, leading to gp130 degradation.
  • Inhibition of caspase 3 or 8 significantly prevented gp130 degradation.
  • Mutagenesis of the identified gp130 caspase cleavage site (residues 800-806) conferred resistance to cleavage.
  • IL-6-induced phosphorylation of STAT3 and SHP2 was suppressed by CD95L.
  • A ~18kDa C-terminal gp130 cleavage product release was inhibited by mutagenesis.

Conclusions:

  • CD95L antagonizes IL-6 signaling through caspase-mediated cleavage of gp130.
  • This gp130 cleavage disrupts downstream IL-6 signaling pathways.
  • The findings suggest a mechanism by which CD95L may counteract IL-6's hepatoprotective effects.

More Related Videos

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation08:47

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

Published on: March 5, 2018

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex07:17

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex

Published on: August 2, 2021

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.